← Leaderboards
John Goertz
Imperial College Of Science, Technology And Medicine
$178,293
Attributed
$178,293
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $64.9K · FY2019–21$100K$75K$50K$25K$0
'19
'20
'21
Funding mix
By agency
NIH$178,293 · 1
By mechanism
F32$178,293 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Antibiotics”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
AntibioticsArchitectureAttentionBacteriaBehaviorBindingBiochemicalBiological SciencesBiomedical ResearchCareerCell CompartmentationCellsCharacteristicsChemical ConjugateChronic InfectionCommunicationComplexCytokineDesignDetectionDiagnosisDiagnosticDiffuseAntibiotic Resistance
Grant awards (6)
A SERS nanoneedle system for studying Staphylococcus aureus survival in live cells$40,663
F32 · FY2021 · GM · contact PI
A SERS nanoneedle system for studying Staphylococcus aureus survival in live cells$11,850
F32 · FY2021 · GM · contact PI
A SERS nanoneedle system for studying Staphylococcus aureus survival in live cells$53,076
F32 · FY2020 · GM · contact PI
A SERS nanoneedle system for studying Staphylococcus aureus survival in live cells$11,850
F32 · FY2020 · GM · contact PI
A SERS nanoneedle system for studying Staphylococcus aureus survival in live cells$50,004
F32 · FY2019 · GM · contact PI
A SERS nanoneedle system for studying Staphylococcus aureus survival in live cells$10,850
F32 · FY2019 · GM · contact PI